Trending Tickers: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Office Depot, Inc. (NASDAQ:ODP), Concurrent Computer Corporation (NASDAQ:CCUR), Oncothyreon Inc (NASDAQ:ONTY),

Zacks Investment Research upgraded shares of Rexahn Pharmaceuticals, Inc. (NYSE:RNN) from a hold rating to a buy rating in a report issued on Tuesday, Market Beatreports. The firm currently has $0.50 price target on the biopharmaceutical company’s stock.

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) belongs to Healthcare sector. Its weekly performance is -4.86%. On last trading day company shares ended up at $0.37. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) distance from 50-day simple moving average (SMA50) is 4.24%.

On 24 February, Office Depot, Inc. (NASDAQ:ODP) announced that education solution experts from its new “Committed to Learning” initiative are working with Wallingford Public Schools to design 10 kindergarten and pre-kindergarten classes, and to enable electronic collaboration with interactive touchscreens in classrooms across all grade levels.

Office Depot, Inc. (NASDAQ:ODP) shares fell -0.58% in last trading session and ended the day at $5.18. ODP Gross Margin is 24.20% and its return on assets is 0.10%. Office Depot, Inc. (NASDAQ:ODP) quarterly performance is -21.40%.

Concurrent Computer Corporation (NASDAQ:CCUR) announced that the Company is exploring strategic alternatives to maximize shareholder value. The Board of Directors has created a special committee of directors and the Company has engaged Needham & Company, LLC to advise it on the process.

On 02 March, Concurrent Computer Corporation (NASDAQ:CCUR) shares fell -0.68% and was closed at $5.85. CCUR EPS growth in last 5 year was 19.70%. Concurrent Computer Corporation (NASDAQ:CCUR) year to date (YTD) performance is 18.18%.

On 29 February, Oncothyreon Inc (NASDAQ:ONTY) announced dosing of the first patient in a randomized, placebo-controlled Phase 2 trial of ONT-380 in combination with Herceptin® (trastuzumab) and Xeloda® (capecitabine).

Oncothyreon Inc (NASDAQ:ONTY) ended the last trading day at $1.07. Company weekly volatility is calculated as 8.13% and price to cash ratio as 1.59. Oncothyreon Inc (NASDAQ:ONTY) showed a weekly performance of 13.83%.

On 27 February, Apple Inc. (NASDAQ:AAPL) said that, it is expected to hold a special media event where it will announce the iPhone SE, along with a new iPad Pro model and some minor Apple Watch enhancements, sometime next month.

On 02 March, Apple Inc. (NASDAQ:AAPL) shares advanced 0.22% and was closed at $100.75. AAPL EPS growth in last 5 year was 33.70%. Apple Inc. (NASDAQ:AAPL) year to date (YTD) performance is -3.77%.

Leave a Reply

Your email address will not be published. Required fields are marked *